Novel therapeutic approach identified for overcoming resistance in B-cell leukemia
Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove challenging to treat, with survival among relapsed or resistant cases falling between 30-50%.
Source: news-medical.net